Annual EBITDA
-$41.48 M
-$31.17 M-302.34%
31 December 2023
Summary:
Co-Diagnostics annual earnings before interest, taxes, depreciation & amortization is currently -$41.48 million, with the most recent change of -$31.17 million (-302.34%) on 31 December 2023. During the last 3 years, it has fallen by -$83.31 million (-199.15%). CODX annual EBITDA is now -189.39% below its all-time high of $46.40 million, reached on 31 December 2021.CODX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$9.88 M
-$2.54 M-34.63%
30 September 2024
Summary:
Co-Diagnostics quarterly earnings before interest, taxes, depreciation & amortization is currently -$9.88 million, with the most recent change of -$2.54 million (-34.63%) on 30 September 2024. Over the past year, it has dropped by -$1.24 million (-14.40%). CODX quarterly EBITDA is now -161.44% below its all-time high of $16.09 million, reached on 31 December 2020.CODX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$38.67 M
-$1.24 M-3.32%
30 September 2024
Summary:
Co-Diagnostics TTM earnings before interest, taxes, depreciation & amortization is currently -$38.67 million, with the most recent change of -$1.24 million (-3.32%) on 30 September 2024. Over the past year, it has increased by +$1.73 million (+4.29%). CODX TTM EBITDA is now -172.55% below its all-time high of $53.30 million, reached on 31 March 2021.CODX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CODX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -302.3% | -14.4% | +4.3% |
| 3 y3 years | -199.2% | -172.0% | -174.3% |
| 5 y5 years | -581.5% | -471.1% | -528.1% |
CODX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -189.4% | at low | -172.0% | +15.4% | -174.3% | +7.4% |
| 5 y | 5 years | -189.4% | at low | -161.4% | +15.4% | -172.6% | +7.4% |
| alltime | all time | -189.4% | at low | -161.4% | +15.4% | -172.6% | +7.4% |
Co-Diagnostics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9.88 M(+34.6%) | -$38.67 M(+3.3%) |
| June 2024 | - | -$7.34 M(-26.1%) | -$37.42 M(-10.4%) |
| Mar 2024 | - | -$9.93 M(-13.8%) | -$41.77 M(+0.7%) |
| Dec 2023 | -$41.48 M(+302.3%) | -$11.51 M(+33.3%) | -$41.48 M(+2.7%) |
| Sept 2023 | - | -$8.64 M(-26.1%) | -$40.40 M(+6.4%) |
| June 2023 | - | -$11.69 M(+21.3%) | -$37.98 M(+26.5%) |
| Mar 2023 | - | -$9.63 M(-7.7%) | -$30.01 M(+191.2%) |
| Dec 2022 | -$10.31 M(-122.2%) | -$10.43 M(+67.7%) | -$10.31 M(-197.8%) |
| Sept 2022 | - | -$6.22 M(+67.2%) | $10.54 M(-65.4%) |
| June 2022 | - | -$3.72 M(-137.0%) | $30.48 M(-33.8%) |
| Mar 2022 | - | $10.07 M(-3.3%) | $46.07 M(-0.7%) |
| Dec 2021 | $46.40 M(+10.9%) | $10.41 M(-24.1%) | $46.40 M(-10.9%) |
| Sept 2021 | - | $13.72 M(+15.7%) | $52.08 M(+3.3%) |
| June 2021 | - | $11.86 M(+14.0%) | $50.42 M(-5.4%) |
| Mar 2021 | - | $10.40 M(-35.3%) | $53.30 M(+27.4%) |
| Dec 2020 | $41.83 M | $16.09 M(+33.2%) | $41.83 M(+74.1%) |
| Sept 2020 | - | $12.07 M(-18.1%) | $24.03 M(+135.0%) |
| June 2020 | - | $14.73 M(-1488.4%) | $10.23 M(-275.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$1.06 M(-38.2%) | -$5.84 M(-3.1%) |
| Dec 2019 | -$6.02 M(-1.0%) | -$1.72 M(-0.9%) | -$6.02 M(-2.2%) |
| Sept 2019 | - | -$1.73 M(+30.3%) | -$6.16 M(+2.5%) |
| June 2019 | - | -$1.33 M(+6.4%) | -$6.01 M(-0.5%) |
| Mar 2019 | - | -$1.25 M(-32.5%) | -$6.04 M(-0.8%) |
| Dec 2018 | -$6.09 M(-7.8%) | -$1.85 M(+17.0%) | -$6.09 M(+6.2%) |
| Sept 2018 | - | -$1.58 M(+16.2%) | -$5.73 M(-28.5%) |
| June 2018 | - | -$1.36 M(+4.8%) | -$8.02 M(+9.1%) |
| Mar 2018 | - | -$1.30 M(-13.0%) | -$7.35 M(+11.3%) |
| Dec 2017 | -$6.60 M(+300.1%) | -$1.49 M(-61.4%) | -$6.60 M(+19.0%) |
| Sept 2017 | - | -$3.87 M(+460.4%) | -$5.55 M(+168.5%) |
| June 2017 | - | -$689.90 K(+24.4%) | -$2.07 M(+17.6%) |
| Mar 2017 | - | -$554.60 K(+27.0%) | -$1.76 M(-43.8%) |
| Dec 2016 | -$1.65 M(-14.3%) | -$436.60 K(+13.4%) | -$3.13 M(+16.2%) |
| Sept 2016 | - | -$385.10 K(+1.0%) | -$2.69 M(+16.7%) |
| June 2016 | - | -$381.40 K(-80.2%) | -$2.31 M(+19.8%) |
| Mar 2016 | - | -$1.92 M | -$1.92 M |
| Dec 2015 | -$1.92 M | - | - |
FAQ
- What is Co-Diagnostics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Co-Diagnostics?
- What is Co-Diagnostics annual EBITDA year-on-year change?
- What is Co-Diagnostics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Co-Diagnostics?
- What is Co-Diagnostics quarterly EBITDA year-on-year change?
- What is Co-Diagnostics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Co-Diagnostics?
- What is Co-Diagnostics TTM EBITDA year-on-year change?
What is Co-Diagnostics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CODX is -$41.48 M
What is the all time high annual EBITDA for Co-Diagnostics?
Co-Diagnostics all-time high annual earnings before interest, taxes, depreciation & amortization is $46.40 M
What is Co-Diagnostics annual EBITDA year-on-year change?
Over the past year, CODX annual earnings before interest, taxes, depreciation & amortization has changed by -$31.17 M (-302.34%)
What is Co-Diagnostics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CODX is -$9.88 M
What is the all time high quarterly EBITDA for Co-Diagnostics?
Co-Diagnostics all-time high quarterly earnings before interest, taxes, depreciation & amortization is $16.09 M
What is Co-Diagnostics quarterly EBITDA year-on-year change?
Over the past year, CODX quarterly earnings before interest, taxes, depreciation & amortization has changed by -$1.24 M (-14.40%)
What is Co-Diagnostics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CODX is -$38.67 M
What is the all time high TTM EBITDA for Co-Diagnostics?
Co-Diagnostics all-time high TTM earnings before interest, taxes, depreciation & amortization is $53.30 M
What is Co-Diagnostics TTM EBITDA year-on-year change?
Over the past year, CODX TTM earnings before interest, taxes, depreciation & amortization has changed by +$1.73 M (+4.29%)